Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPD

BACKGROUND: This study forms part of the first complete characterization of the dose–response curve for glycopyrrolate (GP) delivered using Co-Suspension™ Delivery Technology via a metered dose inhaler (MDI). We examined the lower GP MDI dose range to determine an optimal dose for patients with mode...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Respir Res
Main Authors: Fabbri, Leonardo M., Kerwin, Edward M., Spangenthal, Selwyn, Ferguson, Gary T., Rodriguez-Roisin, Roberto, Pearle, James, Sethi, Sanjay, Orevillo, Chad, Darken, Patrick, St. Rose, Earl, Fischer, Tracy, Golden, Michael, Dwivedi, Sarvajna, Reisner, Colin
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5009486/
https://ncbi.nlm.nih.gov/pubmed/27586537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-016-0426-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados